SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000932440-08-000130
Filing Date
2008-02-14
Accepted
2008-02-14 13:39:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDED sched13g_1262519.htm SC 13G/A 135218
2 EXHIBIT 99.1 - JOINT FILING AGREEMENT ex99-1_1262517.htm EX-99 29408
  Complete submission text file 0000932440-08-000130.txt   166623
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81457 | Film No.: 08612516
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022 212-624-2567
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A